MAM
Yahoo India sponsored Effie 2003 awards on 22 August in Mumbai
MUMBAI: The second edition of the Effie Awards, organized by Advertising Club of Bombay, will be announced in a ceremony held at the Taj Lands End Mumbai on 22 August 2003. Sponsors of the event, the Internet communications, commerce and media company, Yahoo! India will be bringing the awards for effectiveness in advertising for the second time.
According to Yahoo release, the Effie Awards reward campaigns that worked for the clients most effectively. With help of its association with the Effie 2003, Yahoo! India claims to play a role in getting more agency media and creative people aware of the potency of the on line advertising. This association will draw the attention of a audience comprising planners, creative directors, strategists and writers to use the net as an effective medium.
Besides the educative efforts during the award ceremony, Yahoo! India has created a website dedicated to providing effective marketing solutions to its clients. The site http://solutions.yahoo.co.in has been built to provide marketers with a wide range of marketing solutions and tools to help them leverage the Yahoo! Network, to meet their marketing objectives.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
